LI Zon

1.3k citations
11 papers · 1.1k indexed · h-index 8
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers)Chronic Lymphocytic Leukemia Research (3 papers)Zebrafish Biomedical Research Applications (3 papers)
Journals
Blood
Partner nations
United StatesIndiaChina

In The Last Decade

LI Zon

11 papers receiving 1.0k citations

Peers

LI Zon
Comparison fields: 5 of 78
  • Molecular Biology 509
  • Cell Biology 313
  • Hematology 307
  • Immunology 301
  • Genetics 162
Replace Claude Griscelli with:
Claude Griscelli France
Suzanne Skoda‐Smith United States
E T Dayton United States
Cathleen Cooper United States
Mickaël Ménager France
Yoshiaki Hatano Japan
Blair Ardman United States
Priscilla Yam United States
Ichiro Nishikata Japan
Kimmo K. Karhi Finland
LI Zon relative to Claude Griscelli France Claude Griscelli's profile →
Citations per field
00.5×3.2×
Claude Griscelli · 1×
Citations per year

Countries citing papers authored by LI Zon

Since Specialization
Citations

This map shows the geographic impact of LI Zon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LI Zon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LI Zon more than expected).

Fields of papers citing papers by LI Zon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LI Zon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LI Zon. The network helps show where LI Zon may publish in the future.

Co-authorship network of co-authors of LI Zon

This figure shows the co-authorship network connecting the top 25 collaborators of LI Zon. A scholar is included among the top collaborators of LI Zon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LI Zon. LI Zon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1
Analysis of epidemioiogical characteristics on human infection with avian influenza H7N9 virus cases
4
2
POLYCHROMATIC SETS AND ITS APPLICATION IN SIMULATION OF COMPLEX OBJECT AND SYSTEM
3
3 159
4 242
5 213
6 2
7 7
8 164
9 15
10 115
11 141

About LI Zon

LI Zon is a scholar working on Genetics, Cell Biology and Hematology, having authored 11 papers that have together received 1.1k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Zebrafish Biomedical Research Applications (3 papers). The work is most often cited by research in Hematology (307 citations), Virology (103 citations) and Cell Biology (313 citations). LI Zon has collaborated with scholars based in United States, India and China. Frequent co-authors include DT Scadden, JE Groopman, Karen O. Yee, Yuji Yamaguchi, S.J. Ackerman, Akira Kimura, SH Orkin, Mitsugu Maéno, HF Kung and Atsushi Suzuki. Their work appears in journals such as Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026